The provided UK guideline excerpts do not contain specific information regarding follow-up care for patients diagnosed with soft tissue sarcoma after referral to a specialist.
The available guidelines focus on follow-up care for other conditions, such as brain tumours and melanoma NICE NG99,NICE NG14. For instance, follow-up for brain tumours involves surveillance for late-onset side effects of treatment, including cataracts, cognitive decline, epilepsy, and secondary tumours, with assessments for individual risk and lifestyle advice NICE NG99. For melanoma, follow-up is personalised based on risk factors and disease stage, involving clinic appointments, imaging (such as whole-body and brain MRI or CE-CT), and psychosocial support NICE NG14.